Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma. [PDF]
Cheng Z +7 more
europepmc +1 more source
Conservation of Human IgSF Proteins Throughout Eukaryotic Evolution. [PDF]
Grudman S, Fiser A.
europepmc +1 more source
Immunoexpression of programmed death receptor 1 and its ligands in oral cavity squamous cell carcinoma. [PDF]
Anjos RS +5 more
europepmc +1 more source
Ipilimumab, -omics, and head and neck cancers-update in 2025. [PDF]
Kucharski R +3 more
europepmc +1 more source
Immunological mechanisms and antibody-drug conjugates targeting B7-H3 and B7-H4 in ovarian cancer. [PDF]
Brown EF +3 more
europepmc +1 more source
Investigating the activation of the immune response by outer membrane vesicles from Bacteroides fragilis using a human gastrointestinal cell system. [PDF]
Jefferis TM +7 more
europepmc +1 more source
Tumor-Associated Macrophages in Hepatocellular Carcinoma: From Ontogeny and Heterogeneity to Immune Evasion and Therapeutic Targeting. [PDF]
Su Y +5 more
europepmc +1 more source
A novel TM4SF4-targeting therapeutic antibody candidate with antitumor activity by blocking IGF1R and CD44 signaling and downregulating PD-L1 and B7-H4. [PDF]
Kim RK +14 more
europepmc +1 more source
From M7824 to SHR-1701: lessons for dual PD-L1/TGF-β targeting. [PDF]
Yi M, Li T, Wu K, Dai Z.
europepmc +1 more source
Regulation and Mechanism of Deleted in Breast Cancer-1 on Dendritic Cell Function in Systemic Lupus Erythematosus. [PDF]
Xiao ZX +9 more
europepmc +1 more source

